Trials / Completed
CompletedNCT02449941
Helicobacter Pylori and Proton Pump Inhibitor
Distribution of Helicobacter Pylori According to the Use of Proton Pump Inhibitor
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to know the distribution of HP in stomach before use of PPI, during use of PPI, and after stop of PPI.
Detailed description
Endoscopy and biopsy will be performed to investigate the distrubition of HP before, during, and after using PPI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PPI (proton pump inhibitor) | 1. Pre ESD (endoscopic submucosal dissection) * Assessment atrophy and metaplasia in stomach, Check Helicobacter pylori * Use of PPI for 2 months 2. Post ESD 1 (After 2 months) * Assess the distribution of helicobacter pylori after using PPI. * Stop of PPI 3. Post ESD 2 (After 4 months) * Assess the distribution of helicobacter pylori after stop of PPI. |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2015-05-21
- Last updated
- 2016-12-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02449941. Inclusion in this directory is not an endorsement.